Fighting IF On 04/03/2008
Why synthetic estrogens wreak havoc on reproductive system Annotated
tags: estrogens, fertility, fertility problems, synthetic estrogen
Researchers at Yale School of Medicine now have a clearer understanding of why synthetic estrogens such as those found in many widely-used plastics have a detrimental effect on a developing fetus, cause fertility problems, as well as vaginal and breast cancers.
Preliminary results of the study will be presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California. The study was led by Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Science and section chief of Reproductive Endocrinology and Infertility at Yale School of Medicine.
Past research shows that exposure to the synthetic estrogen diethylstilbestrol (DES) alters the expression of HOXA10, a gene necessary for uterine development, and increases the risk of cancer and pregnancy complications in female offspring.
The team sought to understand why a developing female fetus exposed to DES might develop uterine cancer and other problems years after exposure. Even though DES is no longer on the market, the authors chose to study its effects to gain insight into how similar synthetic estrogens might work.
Researchers at Yale School of Medicine now have a clearer understanding of why synthetic estrogens such as those found in many widely-used plastics have a detrimental effect on a developing fetus, cause fertility problems, as well as vaginal and breast cancers.
Preliminary results of the study will be presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California. The study was led by Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Science and section chief of Reproductive Endocrinology and Infertility at Yale School of Medicine.
Past research shows that exposure to the synthetic estrogen diethylstilbestrol (DES) alters the expression of HOXA10, a gene necessary for uterine development, and increases the risk of cancer and pregnancy complications in female offspring.
The team sought to understand why a developing female fetus exposed to DES might develop uterine cancer and other problems years after exposure. Even though DES is no longer on the market, the authors chose to study its effects to gain insight into how similar synthetic estrogens might work.
David Adamson, MD Named President of the American Society for Reproductive Medicine: Financial News - Yahoo! Finance Annotated
tags: adamson, endocrinologist, fertility, reproductive medicine
Fertility Physicians of Northern California (FPNC), a private medical practice dedicated to helping people facing infertility, announced today that its founder, David Adamson, MD, has taken office as President of the American Society for Reproductive Medicine (ASRM), the nation's leading organization for reproductive medicine and science.
Dr. Adamson assumed the presidency at the 8,000 plus member society's annual meeting in October 2007. He previously served a year as the organization's president-elect. In his term as president, Dr. Adamson will be Chairman of the Executive Committee and Board of Directors, and lead the world's largest organization of reproductive professionals in all aspects of its educational, scientific and advocacy missions.
Dr. Adamson is a sought-after clinician and researcher. He is a board-certified reproductive endocrinologist, surgeon, and Director of Fertility Physicians of Northern California, in San Jose and Palo Alto, in addition to serving as Adjunct Clinical Professor at Stanford University School of Medicine and Associate Clinical Professor at the University of California San Francisco School of Medicine.
Northern California (FPNC), a private medical practice dedicated to helping
people facing infertility, announced today that its founder, David Adamson,
MD, has taken office as President of the American Society for Reproductive
Medicine (ASRM), the nation's leading organization for reproductive medicine
and science.
|
Dr. Adamson assumed the presidency at the 8,000 plus member society's
annual meeting in October 2007. He previously served a year as the
organization's president-elect. In his term as president, Dr. Adamson will be
Chairman of the Executive Committee and Board of Directors, and lead the
world's largest organization of reproductive professionals in all aspects of
its educational, scientific and advocacy missions.
Dr. Adamson is a sought-after clinician and researcher. He is a
board-certified reproductive endocrinologist, surgeon, and Director of
Fertility Physicians of Northern California, in San Jose and Palo Alto, in
addition to serving as Adjunct Clinical Professor at Stanford University
School of Medicine and Associate Clinical Professor at the University of
California San Francisco School of Medicine.
Related Posts
Leave a comment